OBJECTIVE: @entity428 ( @entity428 ) monitoring is frequently used in intensive care treatment of @entity1 with @entity932 . Data demonstrating an improved outcome from this intervention are lacking. We analyzed standardized mortality ratios in @entity1 with and without @entity428 monitoring to determine its efficacy. DESIGN: A nonrandomized study of case records of consecutively admitted intensive care unit (ICU) @entity1 with @entity932 . SETTING: General and medical ICU of a 900-bed tertiary-care hospital. @entity1 : A total of 225 @entity1 with @entity932 (mainly nontraumatic) admitted consecutively between April 1997 and March 2000. MEASUREMENTS: Simplified Acute Physiology Score (SAPS) II, diagnosis, age, sex, use of @entity428 monitoring, and in-hospital mortality rates were collected from the hospital's ICU database. Expected mortality was provided by means of SAPS II. Standardized mortality ratios were calculated and compared in 119 @entity1 with @entity428 monitoring and 106 @entity1 without @entity428 monitoring. MAIN RESULTS: The case mix-adjusted hospital mortality in the group with @entity428 monitoring was in the expected range (standardized mortality ratio, 1.09 [95% confidence interval (CI), 0.87-1.31]). @entity1 without @entity428 monitoring had a significantly higher standardized mortality ratio than expected (1.26 [95% CI, 1.06-1.46]). CONCLUSIONS: A beneficial effect of @entity428 monitoring in @entity1 with @entity932 may be reflected in an improved standardized mortality ratio.

@entity428 monitoring and case mix-adjusted mortality in XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'PATIENTS'] @entity932 :: ('MESH:D020300', 'Disease') :: ['intracranial hemorrhage'] @entity428 :: ('MESH:D019586', 'Disease') :: ['Intracranial pressure', 'ICP']
@entity932 :: (MESH:D020300,Disease) :: ['intracranial hemorrhage']
